H.R. 5582 · 115th Congress

Abuse Deterrent Access Act of 2018

Stage
Passed a chamber
Introduced
2018-04-23
Latest action
2018-06-13 · Received in the Senate and Read twice and referred to the Committee on Finance.

Summary

Abuse Deterrent Access Act of 2018

(Sec. 2) This bill requires the Centers for Medicare & Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in a prescription drug plan under Medicare or Medicare Advantage (MA). The report must account for any barriers preventing enrollees from accessing such formulations under Medicare or MA.